Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
This case description elaborates on the pilot implementation of the innovative, participatory PM&E tools of War Child Holland’s psychosocial life skills intervention ‘ I DEAL’. The action research aimed to identify ways that work best for I DEAL facilitators to learn and act on basis of their ...PM&E.
more
Dissertation submitted in part fulfilment of the requirements for a Masters degree at the Centre for International Health and Development (CIHD) at University College London (UCL) Institute of Child Health (ICH)
The user has given permission for the uploaded document to be reproduced and made publi...cly available on the source website
more
PLoS ONE 7(12): e52986. doi:10.1371/journal.pone.0052986. Opern Access please download from the website
В качестве социальных предикторов, определяющих рост частоты психических заболеваний, рассматривают процессы урбанизации, стрессогенные события и другие социал...ные тенденции современного мира. Отмечается их прямая связь с манифестацией психических расстройств, в том числе шизофренией. Наиболее подвержены психическим расстройствам лица, находящиеся в неблагоприятной жизненной ситуации или малоимущие. По тяжести социальных последствий и по нарушению адаптации шизофрения продолжает лидировать в психиатрии. Течение шизофрении является одним из основных клинических предикторов медицинского и социального прогноза. Проведенное исследование устанавливает, что клинические предикторы, определяющие тяжесть состояния больных с незлокачественным течением шизофрении, не являются облигатными в социализации данной категории больных.
http://www.ssmj.ru/system/files/201201_105-107_.pdf
more
Q2: For people with dementia, does memantine, when compared to placebo/comparator, produce benefits/harm in the specified outcomes in non-specialist health settings?
Q 4: Is behavioural activation better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with de...pressive episode/disorder?
more
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
Q3: Are pharmacotherapies safe and effective for the treatment of psychostimulant dependence (maintenance or relapse prevention) in non-specialized settings?
Q10: Are antidepressants (Tricyclic antidepressants (TCA), Selective serotonin reuptake inhibitors (SSRIs)) effective and safe in children 6-12 years of age with depressive episode/disorder?
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?